Konkan

GervanoRA Data Services (GDS) Announces the Strategic Partnering Collaboration Agreement with DelveInsight Business Research

Retrieved on: 
Monday, July 6, 2020

Verna, Goa, India, July 06, 2020 (GLOBE NEWSWIRE) -- GervanoRA Data Services (GDS) is pleased to announce the Strategic Partnering Collaboration Agreement with DelveInsight Business Research.

Key Points: 
  • Verna, Goa, India, July 06, 2020 (GLOBE NEWSWIRE) -- GervanoRA Data Services (GDS) is pleased to announce the Strategic Partnering Collaboration Agreement with DelveInsight Business Research.
  • With this partnering, GervanoRA is expecting to utilize expertise resources from DelveInsight to add on existing expertise of GervanoRA to serve our global clientele with quality services at affordable prices.
  • GervanoRA Data Services team is excited about our new Strategic Partnering Collaboration Agreement with DelveInsight.
  • GervanoRA is a known premier provider of syndicated research reports, custom research reports and consulting services, based in Goa, India.

Olon Acquires Manufacturing Facility in India

Retrieved on: 
Monday, September 3, 2018

Olon S.p.A., a world leading Active Pharmaceutical Ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier, announced today the acquisition of a local generics chemical operations API manufacturing facility in Mahad, India, as part of a continuing expansion of its global footprint.

Key Points: 
  • Olon S.p.A., a world leading Active Pharmaceutical Ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier, announced today the acquisition of a local generics chemical operations API manufacturing facility in Mahad, India, as part of a continuing expansion of its global footprint.
  • Paolo Tubertini, CEO of Olon, commented, "By acquiring a manufacturing base in India, Olon will have the opportunity to accelerate growth by adding new CDMO projects and to develop new generic products for the Indian market.
  • The acquisition of the Mahad API manufacturing facility is expected to be completed in early 2019, following a transition process.
  • Always considering human safety and environmental security, Olon handles different and not-common manufacturing process technologies, such as Fluorination, Carbonylation and Fermentation.

Olon Acquires Manufacturing Facility in India

Retrieved on: 
Monday, September 3, 2018

MILAN, Sept. 3, 2018 /PRNewswire/ -- Olon S.p.A., a world leading Active Pharmaceutical Ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier, announced today the acquisition of a local generics chemical operations API manufacturing facility in Mahad, India, as part of a continuing expansion of its global footprint.

Key Points: 
  • MILAN, Sept. 3, 2018 /PRNewswire/ -- Olon S.p.A., a world leading Active Pharmaceutical Ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier, announced today the acquisition of a local generics chemical operations API manufacturing facility in Mahad, India, as part of a continuing expansion of its global footprint.
  • Paolo Tubertini, CEO of Olon, commented, "By acquiring a manufacturing base in India, Olon will have the opportunity to accelerate growth by adding new CDMO projects and to develop new generic products for the Indian market.
  • The acquisition of the Mahad API manufacturing facility is expected to be completed in early 2019, following a transition process.
  • Always considering human safety and environmental security, Olon handles different and not-common manufacturing process technologies, such as Fluorination, Carbonylation and Fermentation.